Related references
Note: Only part of the references are listed.Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer
Amer Amin et al.
BJU INTERNATIONAL (2020)
Which Patients with Negative Magnetic Resonance Imaging Can Safely Avoid Biopsy for Prostate Cancer?
Masakatsu Oishi et al.
JOURNAL OF UROLOGY (2019)
Diagnostic accuracy of 68Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68Ga-PSMA PET to mpMRI
Matthijs J. Scheltema et al.
BJU INTERNATIONAL (2019)
Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patterns
Wen Liu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics
R. S. Eapen et al.
WORLD JOURNAL OF UROLOGY (2019)
Outcomes of magnetic resonance imaging fusion-targeted biopsy of prostate imaging reporting and data system 3 lesions
Tae Jin Kim et al.
WORLD JOURNAL OF UROLOGY (2019)
Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
Sasha C. Druskin et al.
BJU INTERNATIONAL (2018)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
V Kasivisvanathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naive patients
Satoshi Washino et al.
BJU INTERNATIONAL (2017)
The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction
Florian A. Distler et al.
JOURNAL OF UROLOGY (2017)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U. Ahmed et al.
LANCET (2017)
Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect
Nathan Perlis et al.
JOURNAL OF UROLOGY (2017)
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2
Jeffrey C. Weinreb et al.
EUROPEAN UROLOGY (2016)
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2016)
Magnetic Resonance Imaging-targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis
Ivo G. Schoots et al.
EUROPEAN UROLOGY (2015)
Prevalence of High-grade or Insignificant Prostate Cancer in Korean Men With Prostate-specific Antigen Levels of 3.0-4.0 ng/mL
Seung-Kwon Choi et al.
UROLOGY (2015)
Overdiagnosis and Overtreatment of Prostate Cancer
Stacy Loeb et al.
EUROPEAN UROLOGY (2014)
Continuing trends in pathological stage migration in radical prostatectomy specimens
IH Derweesh et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2004)
Share Paper
